Language Selection

Get healthy now with MedBeds!
Click here to book your session

Protect your whole family with Orgo-Life® Quantum MedBed Energy Technology® devices.

Advertising by Adpathway

         

 Advertising by Adpathway

Cardiopulmonary Bypass Complicates Intraoperative Nociception Monitoring During Adult Cardiac Surgery

1 day ago 8

PROTECT YOUR DNA WITH QUANTUM TECHNOLOGY

Orgo-Life the new way to the future

  Advertising by Adpathway

Adequate suppression of nociception remains a fundamental objective of modern cardiac anaesthesia, yet assessing it during operations that involve cardiopulmonary bypass presents substantial difficulties. In a review published in the Journal of Clinical Monitoring and Computing, Vladislav Rogozov, Tomáš Vaněk, and Zuzana Blažejová evaluate the principal physiological limitations that complicate intraoperative nociception monitoring throughout adult cardiac surgery.

Existing nociception monitoring technologies rely on surrogate autonomic, vascular, pupillary, and electroencephalography-derived signals. While several modalities successfully demonstrate responsiveness to surgical stimulation under relatively stable perioperative conditions, many of these surrogate signals become difficult to interpret during cardiopulmonary bypass. Consequently, cardiac-specific validation remains limited, and the extrapolation of available perioperative evidence into cardiopulmonary bypass conditions remains highly uncertain.

According to the authors, the interpretation of intraoperative nociception monitoring during cardiac surgery is directly complicated by profound physiological alterations associated with cardiopulmonary bypass. These disruptive factors include non-pulsatile circulation, cardioplegic arrest, and temperature modulation. In addition, patients undergo haemodilution and systemic inflammatory responses, alongside interventions such as vasoactive support, inotropic support, and pacing, which collectively confound surrogate physiological measurements.

These extensive physiological changes obscure the surrogate autonomic, vascular, pupillary, and electroencephalography-derived signals that contemporary monitors measure to detect nociceptive responses to surgical stimulation. Because cardiopulmonary bypass introduces non-pulsatile circulation, temperature modulation, cardioplegic arrest, pacing, and pharmacological inotropic and vasoactive support simultaneously, evaluating patient nociception using standard monitoring modalities remains an unresolved challenge in adult cardiac surgical practice.

To address these limitations, the review highlights critical priorities for future cardiac-specific validation and the creation of context-aware analytical approaches. Developing analytical methods that account for the unique physiological alterations of cardiopulmonary bypass will be necessary to ensure that nociception monitoring technologies can be reliably interpreted during adult cardiac surgical procedures.

Subject of Research: Physiological limitations of nociception monitoring during cardiopulmonary bypass in adult cardiac surgery

Article Title: Nociception monitoring during cardiac surgery with cardiopulmonary bypass: limitations and future directions

Article References: Rogozov, V., Vaněk, T., & Blažejová, Z. (2026). Nociception monitoring during cardiac surgery with cardiopulmonary bypass: limitations and future directions. Journal of Clinical Monitoring and Computing. https://doi.org/10.1007/s10877-026-01478-0

Image Credits: AI Generated

DOI: 10.1007/s10877-026-01478-0

Keywords: nociception monitoring, cardiopulmonary bypass, cardiac surgery, cardiac anaesthesia, cardioplegic arrest, non-pulsatile circulation, temperature modulation, vasoactive support, inotropic support, cardiac pacing, haemodilution, systemic inflammatory response, autonomic signals, pupillary monitoring, electroencephalography, surgical stimulation, context-aware analysis

Read Entire Article

         

        

Start the new Vibrations with a Medbed Franchise today!  

Protect your whole family with Quantum Orgo-Life® devices

  Advertising by Adpathway